Clik here to view.
AstraZeneca Buys Omthera for $323M, Expands Fleet of Cholesterol Fighters
www.simplesharebuttons.comShare: AstraZeneca Jennifer Booton Published May 28, 2013 FOXBusiness AstraZeneca (AZN) inked a deal on Tuesday to buy Omthera Pharmaceuticals (OMTH) for $323 million,...
View ArticleClik here to view.
AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3...
www.simplesharebuttons.comShare: selumetinib Array Biopharma To Report Top-line Results From ARRY-502 Asthma Trial Sacramento Bee AstraZeneca began a pivotal trial with selumetinib (an Array-invented...
View ArticleClik here to view.
AstraZeneca: FDA-RESUBMISSION OF THE NDA FOR DAPAGLIFLOZIN FOR THE TREATMENT...
www.simplesharebuttons.comShare: DAPAGLIFLOZIN AstraZeneca and Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug...
View ArticleClik here to view.
AstraZeneca pays $50 million upfront for Merck & Co cancer drug
www.simplesharebuttons.comShare: AstraZeneca has licensed a drug which is in mid-stage studies for ovarian cancer from Merck & Co. The pact centres around the US drug major’s MK-1775, an oral small...
View ArticleClik here to view.
European Commission approves Fluenz Tetra for the prevention of seasonal...
www.simplesharebuttons.comShare: Friday, 6 December 2013 AstraZeneca today announced that the European Commission (EC) has granted Marketing Authorisation to FluenzTM Tetra. Fluenz Tetra is a nasally...
View ArticleClik here to view.
AZD 7594
Share: . Picture credit….Bethany Halford AZD 7594 $AZN‘s asthma candidate AZ13189620; AZD-7594 Bayer Pharma Aktiengesellschaft, Astrazeneca Ab Molecular Formula: C32H32F2N4O6 Molecular Weight:...
View Article
